XML 51 R24.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 17 - Restructuring Costs | 12 Months Ended
--- | ---
Jun. 30, 2024
Notes to Financial Statements |
Restructuring and Related Activities Disclosure [Text Block] | Note 17 - Restructuring Costs As part of the Company’s previously announced restructuring activities related to the wind down and divestiture of the Consumer Health Segment and the closure of the Grand Prairie, Texas manufacturing site (Rx Segment), the Company has incurred expenses that qualify as exit and disposal costs under U.S. GAAP. These include severance and employee benefit costs as well as other direct separation benefit costs, right of use asset impairment charges, fixed asset and other asset impairment charges, accelerated depreciation of fixed assets, contract termination costs, and inventory write-downs. Severance and employee benefit costs primarily relate to cash severance. The expense associated with severance and employee benefits and exit and disposal activities are included in restructuring costs in the consolidated statements of operations and expense associated with inventory write-downs is recorded in cost of sales in the consolidated statements of operations. The Company does not expect to incur any additional significant restructuring costs related to the wind down and divestiture of the Consumer Health Segment and the closure of the Grand Prairie, Texas manufacturing site during fiscal 2025. As of June 30, 2024, the Company did not have any material accruals related to the wind down of the Consumer Health Segment. As of June 30, 2024, the Company had accrued $0.9 million and $0.4 million related to accrued severance and employee benefits and accrued exit and disposal activity costs, respectively, related to the closure of the Grand Prairie, Texas manufacturing facility. A summary of restructuring costs incurred during the year ended June 30, 2024, is as follows:
​ |  | Year Ended June 30, 2024 |
​ |  | Severance and Employee Benefits (1) |  |  | Exit and Disposal Activities (1) |  |  | Inventory Write-Down (2) |  |  | Total |
​ |  | (in thousands) |
Wind down of Consumer Health Segment (3) |  | $ | 20 |  |  | $ | 189 |  |  | $ | 730 |  |  | $ | 939 |
Closure of Grand Prairie, Texas manufacturing site (4) |  |  | 1,125 |  |  |  | 1,031 |  |  |  | — |  |  |  | 2,156 |
Total |  | $ | 1,145 |  |  | $ | 1,220 |  |  | $ | 730 |  |  | $ | 3,095 |
(1) | Expense associated with severance and employee benefits and exit and disposal activities are included in restructuring costs in the consolidated statements of operations.
(2) | Expense associated with inventory write-downs is recorded in cost of sales in the consolidated statements of operations.
(3) | Expense associated with the wind down of the Consumer Health Segment is related to the Consumer Health Segment.
(4) | Expense associated with the closure of the Grand Prairie, Texas manufacturing site is related to the Rx Segment.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration